283 research outputs found
Validation of a self-reported work disability questionnaire for ulcerative colitis
Ulcerative colitis (UC) may severely limit patients'' capacity to work. Recently, we validated a work disability questionnaire (WDQ) for Crohn disease. As UC shares clinical characteristics with Crohn disease, we hypothesized that the questionnaire might also be useful for UC. The study was aimed to validate the WDQ for use in UC. Consecutive patients with UC (n = 142, 67 women; age 48 +/- 1) completed the UC-WDQ and the inflammatory bowel disease questionnaire-9 (IBDQ-9), and EuroQoL-5D quality-of-life questionnaires. Validation of the UC-WDQ included an assessment of its construct validity, including: discriminant validity, convergent validity, and reproducibility (test-retest). We also calculated the intraclass correlation and the Cronbach alpha. 1. Discriminant validity: Mean UC-WDQ scores were 12.8 +/- 4.4 (remission phase) and 17.2 +/- 6.1 (with clinical activity) (P < .05). 2. Convergent validity: The correlations of UC-WDQ were r = 0.74 (P < .001) with IBDQ, r = 0.44 (P < .01) with disease activity, r = 0.56 (P < .01) with EuroQoL-5D, and r = 0.60 (P < .01) with the EuroQoL-5D visual scale. 3. Reproducibility: Test-retest reproducibility: UC-WDQ scores obtained after a 2-week interval were similar (15.8 vs 15.1), (r = 0.91, P < .01). Intraclass correlation was 0.93 (95% confidence interval 0.92-0.95). Cronbach alpha was 0.94. The UC-WDQ is a valid and reliable tool for measuring work disability in patients with UC
Incidence of Non-Melanoma Skin Cancers in Salento (Southern Italy): A 15-Year Retrospective Analysis from the Cancer Registry of Lecce
Background and Objectives: Non-melanoma skin cancers (NMSCs) include basal cell carcinoma (BCC) and squamous-cell carcinoma (SCC), as well as a wide range of rare skin tumors. NMSCs is the most frequently diagnosed type of tumor among Caucasians. We aimed at estimating the incidence and mortality of NMSCs in the Salento area (Lecce province, Southern Italy), whose population is assumed to experience heavy and frequent sun exposure due to climatic/environmental factors, both for working and leisure activities. Materials and Methods: We computed the incidence of NMSCs in the Province of Lecce by examining the comprehensive real-world data collected by the local cancer registry, which covers all the 830,000 inhabitants, over a period of fifteen years (from 2003 to 2017), with a focus on the latest 5 years (2013–2017) for the analysis of the different histologic morphologies of these tumors. The incidence of NMSCs has been described in terms of absolute frequencies, crude rates and age-adjusted direct standardized rates (DSR). Joinpoint analysis was used to examine temporal trends in the incidence of NMSCs and estimate annual percent changes (APCs). Results: During the period of 2003–2017, the incidence of NMSCs reached a direct standardized rate (DSR) of 162.62 per 100,000 in men (mortality 1.57 per 100,000) and 89.36 per 100,000 in women (mortality 0.52 per 100,000), respectively. The incidence significantly increased among both men and women across the entire period. Basal cell carcinoma (BCC), with its different morphologies, represented about 67.6% of the NMSCs in men (n = 2139 out of a total of 3161 tumors observed between 2013 and 2017) and about 75.8% of the NMSCs in women (n = 1718 out of a total of 2264 tumors from 2013 to 2017), thus accounting for the vast majority of NMSCs. The results are consistent with the literature data carried out both at national and international level. Conclusions: Proper monitoring of this phenomenon through timely reporting and recording of all new NMSC cases is necessary to develop new preventive strategies
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES
Aquaporin-4 (AQP-4), the most important water channel in the brain, is expressed by astrocyte endfeet abutting microvessels. Altered expression levels of AQP-4 and redistribution of the protein throughout the membranes of cells found in glioblastoma multiforme (GBM) lead to development of the oedema often found surrounding the tumour mass. Dysregulation of AQP-4 also occurs in hippocampal sclerosis and cortical dysplasia in patients with refractory partial epilepsy. This work reports on analysis of the relationship between AQP-4 expression and the incidence of epileptic seizures in patients with GBM. Immunohistochemical and PCR techniques were used to evaluate AQP-4 in biopsy specimens from 19 patients with GBM, 10 of whom had a history of seizures prior to surgery. AQP-4 mRNA levels were identical in the two groups of patients, but AQP-4 expression was more frequently detected on the GBM membranes from specimens of patients with seizures than from those without (10 vs. 2,
Let me see: Correlation between 5-ala fluorescence and molecular pathways in glioblastoma: A single center experience
Background: Despite the aggressiveness of multimodal treatment, glioblastoma (GBM) is still a challenge for neurosurgeons, neurooncologists, and radiotherapists. A surgical approach is still a cornerstone in GBM therapeutic management, as the extent of resection is strongly related both to overall survival and progression-free survival. From this perspective, the use of photodynamic molecules could represent an interesting tool to achieve maximal and safe resection. Being able to trace the lesion’s edges, indeed, could allow to improve the extent of resection and to minimize residual tumor while sparing normal tissue. The use of 5-aminolevulinic acid (5-ALA) as a photodynamic tracer is well established due to its strict correlation both with cellularity and metabolic activity of the GBM cell clones. Objective: Our study aims to define whether a different molecular asset of GBM (especially investigating IDH 1/2 mutation, proliferation index, and MGMT promoter methylation) results in different fluorescence expression, possibly because of differences in metabolic pathways due to different genotypes. Methods: Patients undergoing surgery for GBM removal at our Institute (Dep. Of Neurosurgery, Ospedale Città della Salute e della Scienza, University of Turin, Italy) were retrospectively reviewed. Patients with histological diagnosis confirmation and to whom 5-ALA was given before surgery were included. The whole surgical procedure was recorded and then analyzed by three different people (a medical student, a resident, and a senior surgeon with an interest in neurooncology and experience in using 5-ALA) and a score was assigned to the different degrees of intraoperative fluorescence. The degree of fluorescence was then matched with the genotype. Results: A trend of grade 2 fluorescence (i.e., ”strong”) was observed in the IDH 1/2 wild-type (WT) genotype, suggesting a more intense metabolic activity in this particular subgroup, while, no or weak fluorescence was observed more often in the IDH 1/2 mutated tumors, suggesting a lower metabolic activity. No relations were found between fluorescence grade and MGMT promoter methylation or, interestingly, cellularity. As a secondary analysis, more epileptogenicity of the IDH 1/2 mutated GBM was noticed, similarly to other recent literature. Conclusion: Our results do not support the use of 5-ALA as a diagnostic tool, or a way to substitute the molecular profiling, but confirm 5-ALA as a powerful metabolic tracer, able to easily detect the pathological cells, especially in the IDH WT genotype, and in this perspective, further studies will be necessary to better describe the metabolic activity of GBM cells
Proton-air cross section measurement with the ARGO-YBJ cosmic ray experiment
The proton-air cross section in the energy range 1-100 TeV has been measured
by the ARGO-YBJ cosmic ray experiment. The analysis is based on the flux
attenuation for different atmospheric depths (i.e. zenith angles) and exploits
the detector capabilities of selecting the shower development stage by means of
hit multiplicity, density and lateral profile measurements at ground. The
effects of shower fluctuations, the contribution of heavier primaries and the
uncertainties of the hadronic interaction models, have been taken into account.
The results have been used to estimate the total proton-proton cross section at
center of mass energies between 70 and 500 GeV, where no accelerator data are
currently available.Comment: 14 pages, 9 figure
Gamma ray flares from Mrk421 in 2008 observed with the ARGO-YBJ detector
In 2008 the blazar Markarian 421 entered a very active phase and was one of
the brightest sources in the sky at TeV energies, showing frequent flaring
episodes. Using the data of ARGO-YBJ, a full coverage air shower detector
located at Yangbajing (4300 m a.s.l., Tibet, China), we monitored the source at
gamma ray energies E > 0.3 TeV during the whole year. The observed flux was
variable, with the strongest flares in March and June, in correlation with
X-ray enhanced activity. While during specific episodes the TeV flux could be
several times larger than the Crab Nebula one, the average emission from day 41
to 180 was almost twice the Crab level, with an integral flux of (3.6 +-0.6)
10^-11 photons cm^-2 s^-1 for energies E > 1 TeV, and decreased afterwards.
This paper concentrates on the flares occurred in the first half of June.
This period has been deeply studied from optical to 100 MeV gamma rays, and
partially up to TeV energies, since the moonlight hampered the Cherenkov
telescope observations during the most intense part of the emission. Our data
complete these observations, with the detection of a signal with a statistical
significance of 3.8 standard deviations on June 11-13, corresponding to a gamma
ray flux about 6 times larger than the Crab one above 1 TeV. The reconstructed
differential spectrum, corrected for the intergalactic absorption, can be
represented by a power law with an index alpha = -2.1 extending up to several
TeV. The spectrum slope is fully consistent with previous observations
reporting a correlation between the flux and the spectral index, suggesting
that this property is maintained in different epochs and characterizes the
source emission processes.Comment: Accepted for publication on ApJ
- …